Hello, Fool! | Login | Signup | My Fool
Dec 5, 2008 9:28 AM ET | Feedback | Site Changes | Help
The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.
View All Commentary (ICLR)
Recs
dollarpimp (26.88) Submitted: 1/18/08 7:38 PM : Start Price: $30.82 ICLR Score: -0.25
Discounted earnings valuation assuming 25% earnings growth over 10 years indicates this stock is selling at a substantial discount. Even assuming 20%, it's fairly priced. Just backed off a new high, buying on the dip. Healthcare sector will outperform.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK